查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1608067

植入式心律管理设备市场：按装置、最终用户划分 - 2025-2030 年全球预测

Implantable Cardiac Rhythm Management Devices Market by Device (Cardiac Resynchronization Therapy, Defibrillators, Pacemakers), End-User (Ambulatory Surgical Centers, Hospitals, Speciality Cardiac Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年植入式心律管理设备市值为135.4亿美元，预计2024年将达到152.3亿美元，复合年增长率为10.16%，2030年将达266.6亿美元，预计将达到1000万美元。

植入式心律管理设备市场范围包括旨在管理心律不整的设备，例如心律调节器、心臟去颤器和心臟再同步治疗设备。这些设备对于透过维持适当的心率和心率来治疗心搏过缓、心搏过速和心臟衰竭至关重要。人口老化、心血管疾病盛行率的增加以及技术进步正在推动这些设备的需求和应用。最终用途包括医院、门诊手术中心和心臟中心，由于意识的提高和医疗保健设施的改善，医院的手术量正在增加。市场成长受到设备技术创新的影响，例如 MRI 相容设备、远端监控系统和无导线心律调节器。新兴市场、不断增长的医疗保健支出以及远端医疗的采用带来了机会。公司可以透过投资先进能力的研发并开拓开拓的市场来利用这些机会。然而，市场成长面临设备成本高、监管核准严格以及设备相关併发症（如感染疾病和设备故障）等限制。竞争因素包括来自替代非侵入性治疗方案的竞争以及某些地区的报销问题。最佳创新领域包括开发可充电电池、增强即时健康资料分析的远端监控功能以及提高患者舒适度和依从性的小型化或生物可吸收材料，其中包括设计等。市场是动态的，以快速的技术发展和监管变化为标誌，要求参与者保持敏捷和响应能力。透过专注于持续创新和策略伙伴关係关係，公司可以克服限制、开拓新客户群并保持成长。因此，市场参与者应在研究中优先考虑适应性策略，遵守不断变化的监管标准，并投资以患者为中心的解决方案，以加强其市场地位。

主要市场统计
基准年[2023] 135.4亿美元
预测年份 [2024] 152.3亿美元
预测年份 [2030] 266.6亿美元
复合年增长率（%） 10.16%

市场动态：快速发展的植入式心律管理设备市场的关键市场洞察

供需的动态交互作用正在改变植入式心律管理设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球心臟病盛行率上升
    • 优惠报销政策
    • 医疗机构采用率提高
  • 市场限制因素
    • 植入式心律管理设备高成本
  • 市场机会
    • 研发费用及新产品推出快速增加
    • 将先进技术融入CRM设备
  • 市场挑战
    • 与CRM设备相关的操作问题

波特五力：驾驭植入式心律管理设备市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解植入式心律管理设备市场的外部影响

外部宏观环境因素在塑造植入式心律管理设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解植入式心律管理设备市场的竞争格局

对植入式心律管理设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵植入式心律管理设备市场供应商的绩效评估

FPNV定位矩阵是评估植入式心律管理设备市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘植入式心律管理设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，植入式心律管理设备市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球心臟病发病率正在上升
      • 优惠退款政策
      • 医疗机构的采用率提高
    • 抑制因素
      • 植入式心律管理设备成本高昂
    • 机会
      • 研发费用及新产品推出快速增加
      • 将先进技术整合到 CRM 设备中
    • 任务
      • 与 CRM 设备相关的操作问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章植入式心律管理设备市场：依设备分类

  • 心臟再同步治疗
    • CRT心臟去颤器
    • CRT心律调节器
  • 心臟去颤器
    • 体外去颤心臟去颤器
    • 植入式心臟整流去颤器
  • 心律调节器
    • 外部的
    • 凹入式

第七章 植入式心律管理设备市场：依最终使用者分类

  • 门诊手术中心
  • 医院
  • 专业心臟中心

第八章美洲植入式心律管理设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太植入式心律管理设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章：欧洲、中东和非洲植入式心律管理设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • BIOTRONIK SE & Co KG
  • Boston Scientific Corporation
  • Hydrix Limited
  • Japan Lifeline Co., Ltd.
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Stryker Corporation
Product Code: MRR-742BD517F8D1

The Implantable Cardiac Rhythm Management Devices Market was valued at USD 13.54 billion in 2023, expected to reach USD 15.23 billion in 2024, and is projected to grow at a CAGR of 10.16%, to USD 26.66 billion by 2030.

The scope of the Implantable Cardiac Rhythm Management Devices market encompasses devices like pacemakers, defibrillators, and cardiac resynchronization therapy devices designed to manage heart rhythm disorders. These devices are essential in treating bradycardia, tachycardia, and heart failure by maintaining adequate heart rates and rhythm. An increasing aging population, rising incidences of cardiovascular diseases, and technological advancements drive the necessity and application of these devices. End-use encompasses hospitals, ambulatory surgical centers, and cardiac centers where the number of procedures is escalating due to growing awareness and improved access to healthcare facilities. Market growth is influenced by innovation in device technologies such as MRI-compatible devices, remote monitoring systems, and leadless pacemakers. Opportunities arise from emerging markets, increasing healthcare expenditure, and the adoption of telemedicine. Companies can capitalize on these opportunities by investing in R&D for advanced functionalities and entering untapped markets. However, market growth faces limitations like high device costs, stringent regulatory approvals, and device-related complications such as infections or device malfunctions. The challenging factors include competition from alternative non-invasive treatment options and reimbursement issues in some regions. The best areas for innovation include developing rechargeable batteries, enhancing remote monitoring capabilities for real-time health data analysis, and designing miniaturized or bioresorbable materials to improve patient comfort and compliance. The market is dynamic, marked by rapid technological evolution and regulatory changes, requiring players to stay agile and responsive. By focusing on continuous innovation and strategic partnerships, firms can overcome constraints, tap into new customer segments, and sustain growth. Therefore, market players should prioritize an adaptable strategy in research, adhering to evolving regulatory standards and investing in patient-centric solutions to bolster their market position.

KEY MARKET STATISTICS
Base Year [2023] USD 13.54 billion
Estimated Year [2024] USD 15.23 billion
Forecast Year [2030] USD 26.66 billion
CAGR (%) 10.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Implantable Cardiac Rhythm Management Devices Market

The Implantable Cardiac Rhythm Management Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cardiac diseases worldwide
    • Favorable reimbursement policies
    • Increasing adoption by the healthcare facilities
  • Market Restraints
    • High cost of implantable cardiac rhythm management devices
  • Market Opportunities
    • Surge in R&D spending and new product launches
    • Integration of advanced technologies in CRM devices
  • Market Challenges
    • Operational issues associated with CRM devices

Porter's Five Forces: A Strategic Tool for Navigating the Implantable Cardiac Rhythm Management Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Implantable Cardiac Rhythm Management Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Implantable Cardiac Rhythm Management Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Implantable Cardiac Rhythm Management Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Implantable Cardiac Rhythm Management Devices Market

A detailed market share analysis in the Implantable Cardiac Rhythm Management Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Implantable Cardiac Rhythm Management Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Implantable Cardiac Rhythm Management Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Implantable Cardiac Rhythm Management Devices Market

A strategic analysis of the Implantable Cardiac Rhythm Management Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Implantable Cardiac Rhythm Management Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BIOTRONIK SE & Co KG, Boston Scientific Corporation, Hydrix Limited, Japan Lifeline Co., Ltd., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., Medtronic plc, MicroPort Scientific Corporation, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Implantable Cardiac Rhythm Management Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device, market is studied across Cardiac Resynchronization Therapy, Defibrillators, and Pacemakers. The Cardiac Resynchronization Therapy is further studied across CRT-Defibrillator and CRT-Pacemakers. The Defibrillators is further studied across External Defibrillator and Implantable Cardioverter Defibrillators. The Pacemakers is further studied across External and Implantable.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Speciality Cardiac Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cardiac diseases worldwide
      • 5.1.1.2. Favorable reimbursement policies
      • 5.1.1.3. Increasing adoption by the healthcare facilities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of implantable cardiac rhythm management devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in R&D spending and new product launches
      • 5.1.3.2. Integration of advanced technologies in CRM devices
    • 5.1.4. Challenges
      • 5.1.4.1. Operational issues associated with CRM devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Implantable Cardiac Rhythm Management Devices Market, by Device

  • 6.1. Introduction
  • 6.2. Cardiac Resynchronization Therapy
    • 6.2.1. CRT-Defibrillator
    • 6.2.2. CRT-Pacemakers
  • 6.3. Defibrillators
    • 6.3.1. External Defibrillator
    • 6.3.2. Implantable Cardioverter Defibrillators
  • 6.4. Pacemakers
    • 6.4.1. External
    • 6.4.2. Implantable

7. Implantable Cardiac Rhythm Management Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals
  • 7.4. Speciality Cardiac Centers

8. Americas Implantable Cardiac Rhythm Management Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Implantable Cardiac Rhythm Management Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Implantable Cardiac Rhythm Management Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. BIOTRONIK SE & Co KG
  • 3. Boston Scientific Corporation
  • 4. Hydrix Limited
  • 5. Japan Lifeline Co., Ltd.
  • 6. Koninklijke Philips N.V.
  • 7. Lepu Medical Technology (Beijing) Co., Ltd.
  • 8. Medtronic plc
  • 9. MicroPort Scientific Corporation
  • 10. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CRT-DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CRT-PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY SPECIALITY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023